Condition
De Quervain Tenosynovitis
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed2
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04895956Phase 4RecruitingPrimary
Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis
NCT06731634Not Yet RecruitingPrimary
De Quervain Syndrome Among Medical Students with Smart Phone Addiction
NCT06651034Not ApplicableCompletedPrimary
Efficacy of Intralesional Platelet Rich Plasma in Patients of De Quervain's Tenosynovitis
NCT06147869Not ApplicableCompletedPrimary
Phonophoresis Versus Low-Level Laser on Dequervain
Showing all 4 trials